M&A Deal Summary

Anika Acquires Fidia Advanced Biopolymers s.r.l.

On December 31, 2009, Anika acquired life science company Fidia Advanced Biopolymers s.r.l. from Fidia Farmaceutici

Acquisition Highlights
  • This is Anika’s 1st transaction in the Life Science sector.
  • This is Anika’s 1st transaction in Italy.

M&A Deal Summary

Date 2009-12-31
Target Fidia Advanced Biopolymers s.r.l.
Sector Life Science
Buyer(s) Anika
Sellers(s) Fidia Farmaceutici
Deal Type Divestiture

Target

Fidia Advanced Biopolymers s.r.l.

Abano Terme, Italy
FAB provides hyaluronic acid-based products in several therapeutic areas including for the regeneration of connective and structural tissues damaged by injuries, aging or degenerative diseases.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Anika

Bedford, Massachusetts, United States

Category Company
Founded 1983
Sector Medical Products
Employees288
Revenue 120M USD (2024)
DESCRIPTION

Anika is a developer, manufacturer and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body. Anika was incorporated in 1983 and is based in Bedford, Massachusetts.


DEAL STATS #
Overall 1 of 3
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Italy M&A 1 of 1
Year: 2009 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-06 Parcus Medical

Sarasota, Florida, United States

Parcus Medical LLC designs, manufacture and distributes implants and instrumentation used by orthopedic surgeons in sports medicine procedures to repair the shoulder, knee, hip, and distal extremities. Parcus Medical was founded in 2007 and is based in Sarasota, Florida.

Buy $35M

Seller(S) 1

SELLER

Fidia Farmaceutici

Abano Terme, Italy

Category Company
Sector Life Science
DESCRIPTION

Fidia operates in therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Italy M&A 1 of 1
Year: 2009 M&A 1 of 1